GlaxoSmithKline plc Profile

USD 0.3  0.73%

GlaxoSmithKline plc Summary

GlaxoSmithKline plc (GSK) is traded on New York Stock Exchange in USA. It is located in UNITED KINGDOM and employs 98,462 people. GlaxoSmithKline plc is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 101.65 B. GlaxoSmithKline plc runs under Healthcare sector within Pharmaceutical Products industry. This company has 4.89 B outstanding shares of which 11.68 M shares are currently shorted by investors with about 3.73 days to cover shorted positions. GLAXOSMITHKLINE P has about 5.41 B in cash with 16.5 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.2.
Check GlaxoSmithKline plc Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 40.73HorizonTargetOdds Above 40.73
49.42%30 days 40.73 49.80%
Based on normal probability distribution, the odds of GlaxoSmithKline plc to move above current price in 30 days from now is about 49.8% (This GlaxoSmithKline plc probability density function shows the probability of GlaxoSmithKline plc Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Dodge CoxCommon Shares48.6 M1.9 B
Royal Bank Of CanadaCommon Shares21.3 M831.9 M
View GlaxoSmithKline plc Diagnostics

Selected GlaxoSmithKline plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

GlaxoSmithKline plc Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for GlaxoSmithKline plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline plc is traded on New York Stock Exchange in USA. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameGlaxoSmithKline plc
CEO, Executive DirectorAndrew WittyView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
InstrumentUSA Stock View All
Business Address980 Great West Road
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number01131399.0
IndustryPharmaceutical Products
Contact Number44 20 8047 5000
CurrencyUSD - US Dollar


GlaxoSmithKline plc Analyst Recommendations
Target PriceAdvice# of Analysts
GlaxoSmithKline plc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
GlaxoSmithKline plc Analyst Advice  


GlaxoSmithKline plc Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.59April 26, 2017
GlaxoSmithKline plc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


GlaxoSmithKline plc Corporate Directors
Vindi Banga Senior Independent Non-Executive Director
Lynn Elsenhans Independent Non-Executive Director
Daniel Podolsky Non-Executive Independent Director
Please also check Risk vs Return Analysis. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.